Lansoprazole | List of Frontiers open access articles

Systematic Review

Published on 05 Sep 2024

Efficacy and safety of vonoprazan versus proton pump inhibitors in the treatment of peptic ulcer disease: a systematic review and network meta-analysis for randomized controlled trails

in Nutrition and Metabolism

Lidi Tian
Dan Xiang
Feili Yue
Runjie Li
Youping Zhou

Frontiers in Nutrition

doi 10.3389/fnut.2024.1436993

13,084 views
3 citations

Original Research

Published on 26 Mar 2024

Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer’s disease seed-dependent formation of tau aggregates

in Alzheimer's Disease and Related Dementias

Ahmed Imtiaz
Shotaro Shimonaka
Mohammad Nasir Uddin
Montasir Elahi
Koichi Ishiguro
Masato Hasegawa
Nobutaka Hattori
Yumiko Motoi

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1368291

6,237 views
3 citations

Original Research

Published on 02 Feb 2021

Lansoprazole-Based Colorimetric Chemosensor for Efficient Binding and Sensing of Carbonate Ion: Spectroscopy and DFT Studies

in Organic Chemistry

Mahdieh Darroudi
Ghodsi Mohammadi Ziarani
Shahriyar Bahar
Jahan B. Ghasemi
Alireza Badiei

Frontiers in Chemistry

doi 10.3389/fchem.2020.626472

6,208 views
25 citations

Original Research

Published on 29 Aug 2025

Risk of interstitial lung disease in non-small cell lung cancer treated with EGFR-TKI: a real-world pharmacovigilance study

in Respiratory Pharmacology

Xu Miao
Yuan Liu
Xiaoqin Li
Rong Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1652750

2,941 views
2 citations

Original Research

Published on 20 Apr 2021

Lansoprazole Alone or in Combination With Gefitinib Shows Antitumor Activity Against Non-small Cell Lung Cancer A549 Cells in vitro and in vivo

in Molecular and Cellular Oncology

Xiaoxia Zhao
Ning Zhang
Yingying Huang
Xiaojing Dou
Xiaolin Peng
Wei Wang
Zhe Zhang
Ran Wang
Yuling Qiu
Meihua Jin

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2021.655559

6,492 views
15 citations

Original Research

Published on 03 Nov 2025

Integrative pharmacovigilance and AI-based framework uncovers potential drug triggers in juvenile idiopathic arthritis

in Systems Immunology

Qiang Luo
Yuxiao Chen
Dawei Liu
Xinlin Wu
Jun Yang
Haiguo Yu
Hongmei Song
Junfeng Wu
Jingyi Zhao
Xuemei Tang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1653003

2,660 views

Systematic Review

Published on 11 Jan 2024

Comparative efficiency and safety of potassium competitive acid blockers versus Lansoprazole in peptic ulcer: a systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Yongqi Dong
Hongyan Xu
Zhihuan Zhang
Zhihang Zhou
Qiang Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1304552

9,699 views
19 citations

Brief Research Report

Published on 15 Jul 2022

Repositioning of Lansoprazole as a Protective Agent Against Cisplatin-Induced Ototoxicity

in Experimental Pharmacology and Drug Discovery

Eri Wakai
Kenji Ikemura
Toshiro Mizuno
Kazuhiko Takeuchi
Satoshi Tamaru
Masahiro Okuda
Yuhei Nishimura

Frontiers in Pharmacology

doi 10.3389/fphar.2022.896760

4,793 views
9 citations

Original Research

Published on 25 Jun 2025

Withania coagulans fruit extract antiulcerogenic effect: comparative study with lansoprazole and ranitidine in rats

in Gastroenterology

Naheed Amir
Hassan Abu Damir
Karam Ghazal-Aswad
Mohamed Hassan
Mukhtar Adem
Mahmoud A. Ali
Salim Bastaki
Ernest Adeghate
Abdu Adem

Frontiers in Medicine

doi 10.3389/fmed.2025.1544422

3,044 views
1 citation

Original Research

Published on 22 Jul 2022

Effect of Acid Suppressants on Non–Helicobacter pylori Helicobacters Within Parietal Cells

in Gastrointestinal and Hepatic Pharmacology

Masahiko Nakamura
Futa Murasato
Anders Øverby
Yosuke Kodama
Hirofumi Michimae
Kazuki Sasaki
Bram Flahou
Freddy Haesebrouck
Somay Y. Murayama
Shinichi Takahashi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.692437

3,292 views
6 citations

Systematic Review

Published on 06 Oct 2022

Effects of CYP2C19 genetic polymorphisms on the cure rates of H. pylori in patients treated with the proton pump inhibitors: An updated meta-analysis

in Pharmacology of Infectious Diseases

Xianghong Zhao
Zhongqiu Zhang
Fang Lu
Mengqiu Xiong
Liping Jiang
Ke Tang
Min Fu
Yu Wu
Bangshun He

Frontiers in Pharmacology

doi 10.3389/fphar.2022.938419

7,026 views
21 citations

Original Research

Published on 27 Mar 2025

Drug-induced kidney stones: a real-world pharmacovigilance study using the FDA adverse event reporting system database

in Renal Pharmacology

Pan Ding
Qinghua Luo
Leihua Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1511115

8,534 views
3 citations

Original Research

Published on 15 Nov 2021

Hepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database

in Gastroenterology

Yifan Zeng
Ying Dai
Ziye Zhou
Xuben Yu
Dawei Shi

Frontiers in Medicine

doi 10.3389/fmed.2021.648164

16,903 views
18 citations

Original Research

Published on 14 Sep 2023

Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study

in Gastrointestinal Infection

Anya Kiattiweerasak
Natsuda Aumpan
Soonthorn Chonprasertsuk
Bubpha Pornthisarn
Sith Siramolpiwat
Patommatat Bhanthumkomol
Pongjarat Nunanan
Navapan Issariyakulkarn
Varocha Mahachai
Yoshio Yamaoka

Frontiers in Gastroenterology

doi 10.3389/fgstr.2023.1245993

6,787 views
4 citations

Original Research

Published on 07 Jan 2019

Standard-Dose Proton Pump Inhibitors in the Initial Non-eradication Treatment of Duodenal Ulcer: Systematic Review, Network Meta-Analysis, and Cost-Effectiveness Analysis

in Gastrointestinal and Hepatic Pharmacology

Jiaxing Zhang
Long Ge
Matt Hill
Yi Liang
Juan Xie
Dejun Cui
Xiaosi Li
Wenyi Zheng
Rui He

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01512

19,759 views
14 citations

Articles

Efficacy and safety of vonoprazan versus proton pump inhibitors in the treatment of peptic ulcer disease: a systematic review and network meta-analysis for randomized controlled trails

Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer’s disease seed-dependent formation of tau aggregates

Lansoprazole-Based Colorimetric Chemosensor for Efficient Binding and Sensing of Carbonate Ion: Spectroscopy and DFT Studies

Risk of interstitial lung disease in non-small cell lung cancer treated with EGFR-TKI: a real-world pharmacovigilance study

Lansoprazole Alone or in Combination With Gefitinib Shows Antitumor Activity Against Non-small Cell Lung Cancer A549 Cells in vitro and in vivo

Integrative pharmacovigilance and AI-based framework uncovers potential drug triggers in juvenile idiopathic arthritis

Comparative efficiency and safety of potassium competitive acid blockers versus Lansoprazole in peptic ulcer: a systematic review and meta-analysis

Repositioning of Lansoprazole as a Protective Agent Against Cisplatin-Induced Ototoxicity

Withania coagulans fruit extract antiulcerogenic effect: comparative study with lansoprazole and ranitidine in rats

Effect of Acid Suppressants on Non–Helicobacter pylori Helicobacters Within Parietal Cells

Effects of CYP2C19 genetic polymorphisms on the cure rates of H. pylori in patients treated with the proton pump inhibitors: An updated meta-analysis

Drug-induced kidney stones: a real-world pharmacovigilance study using the FDA adverse event reporting system database

Hepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database

Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study

Standard-Dose Proton Pump Inhibitors in the Initial Non-eradication Treatment of Duodenal Ulcer: Systematic Review, Network Meta-Analysis, and Cost-Effectiveness Analysis